Soleus Capital Master Fund, L.p. - Net Worth and Insider Trading

Soleus Capital Master Fund, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Soleus Capital Master Fund, L.p. owns 1 companies in total, including Lyra Therapeutics Inc (LYRA) .

Click here to see the complete history of Soleus Capital Master Fund, L.p.’s form 4 insider trades.

Insider Ownership Summary of Soleus Capital Master Fund, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
LYRA	Lyra Therapeutics Inc	2020-05-05	10 percent owner

Soleus Capital Master Fund, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Soleus Capital Master Fund, L.p. Ownership Network

Ownership Network List of Soleus Capital Master Fund, L.p.

No Data

Ownership Network Relation of Soleus Capital Master Fund, L.p.

Soleus Capital Master Fund, L.p. Owned Company Details

What does Lyra Therapeutics Inc do?

Who are the key executives at Lyra Therapeutics Inc?

Soleus Capital Master Fund, L.p. is the 10 percent owner of Lyra Therapeutics Inc. Other key executives at Lyra Therapeutics Inc include director & Executive Chair Harlan Waksal , 10 percent owner Nbvm Gp, Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .

Lyra Therapeutics Inc (LYRA) Insider Trades Summary

Over the past 18 months, Soleus Capital Master Fund, L.p. made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Nbvm Gp, Llc , and a net purchase of 1,805,416 shares made by Edward T Anderson .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lyra Therapeutics Inc Insider Transactions

No Available Data

Soleus Capital Master Fund, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Soleus Capital Master Fund, L.p.. You might contact Soleus Capital Master Fund, L.p. via mailing address: 104 Field Point Road, 2nd Floor, Greenwich Ct 06830.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.